Alessandro Sanna

1.3k total citations
43 papers, 602 citations indexed

About

Alessandro Sanna is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Alessandro Sanna has authored 43 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 17 papers in Genetics and 11 papers in Molecular Biology. Recurrent topics in Alessandro Sanna's work include Acute Myeloid Leukemia Research (18 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Alessandro Sanna is often cited by papers focused on Acute Myeloid Leukemia Research (18 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Alessandro Sanna collaborates with scholars based in Italy, France and United States. Alessandro Sanna's co-authors include Paolo Valera, Patrizia Zavattari, Davide Firinu, Valeria Santini, Alberto Bosi, Antonella Gozzini, Erico Masala, Francesca Buchi, Ana Valencia and Agostino Cortelezzi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Alessandro Sanna

37 papers receiving 596 citations

Peers

Countries citing papers authored by Alessandro Sanna

Since Specialization

Citations

This map shows the geographic impact of Alessandro Sanna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Sanna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Sanna more than expected).

Fields of papers citing papers by Alessandro Sanna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandro Sanna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Sanna. The network helps show where Alessandro Sanna may publish in the future.

Co-authorship network of co-authors of Alessandro Sanna

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Sanna. A scholar is included among the top collaborators of Alessandro Sanna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Sanna. Alessandro Sanna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characteristics of Chemotherapy Side Effects in Patients with Nasopharyngeal Cancer 2025 ·(unknown), (unknown), (unknown), Alessandro Sanna, (unknown), (unknown)	0
2	Management of infections for patient treated with ibrutinib in clinical practice 2024 ·Frontiers in Oncology ·Claudia Baratè, Ilaria Scortechini, (unknown), (unknown), (unknown), Federica Loscocco, Alessandro Sanna, Alessandro Isidori, Paolo Sportoletti	0
3	Real‐world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experience 2023 ·Hematological Oncology ·Luca Laurenti, Lydia Scarfò, Anna Maria Frustaci, Alessandro Sanna, (unknown), Morena Caira, (unknown), (unknown), Benedetta Neri, Stefano Molica, Francesca Romana Mauro	4
4	MDS-462 Response to Erythropoiesis-Stimulating Agent Therapy in IPSS-R Lower Risk Myelodysplastic Syndrome Patients Restratified According to IPSS-M 2023 ·Clinical Lymphoma Myeloma & Leukemia ·(unknown), (unknown), Alessandro Sanna, (unknown), (unknown), (unknown), Giorgio Mattiuz, (unknown), (unknown), Valeria Santini	0
5	Real-life diagnostic and therapeutic approach to CLL: a 2022 update from an expert panel in Tuscany 2023 ·Clinical and Experimental Medicine ·Claudia Baratè, Alessandro Sanna, E. Benedetti, Monica Bocchia, Enrico Capochiani, Romano Danesi, Sabrina Moretti, (unknown), Simone Santini, Sara Galimberti, Alessandro Gozzetti	1
6	Rapid evaluation of T cell clonality in the diagnostic work-up of mature T cell neoplasms: TRBC1-based flow cytometric assay experience 2022 ·Translational Oncology ·Manuela Capone, Benedetta Peruzzi, Boaz Palterer, Sara Bencini, Alessandro Sanna, Benedetta Puccini, Luca Nassi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Roberto Caporale, Francesco Annunziato	11
7	Zinc Status and Autoimmunity: A Systematic Review and Meta-Analysis 2018 ·Nutrients ·Alessandro Sanna, Davide Firinu, Patrizia Zavattari, Paolo Valera	125
8	A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia 2017 ·Leukemia ·Valeria Santini, B Allione, Gina Zini, Daniela Gioia, Monia Lunghi, Antonella Poloni, Daniela Cilloni, Alessandro Sanna, (unknown), Manuela Ceccarelli, Omar Abdel‐Wahab, Adelmo Terenzi, Emanuele Angelucci, Carlo Finelli, Francesco Onida, (unknown), Dario Ferrero, Giuseppe Saglio, María E. Figueroa, Alessandro Levis	54
9	Impact of baseline cytogenetic findings and cytogenetic response on outcome of high-risk myelodysplastic syndromes and low blast count AML treated with azacitidine 2017 ·Leukemia Research ·(unknown), Rami S. Komrokji, Mikkael A. Sekeres, Thomas Prébet, Thomas Cluzeau, Valeria Santini, Emmanuel Gyan, Alessandro Sanna, Najla H. Al Ali, (unknown), Virginie Éclache, Alan F. List, Pierre Fenaux, Lionel Adès	11
10	Is Geo-Environmental Exposure a Risk Factor for Multiple Sclerosis? A Population-Based Cross-Sectional Study in South-Western Sardinia 2016 ·PLoS ONE ·Maria Cristina Monti, Davide Guido, Cristina Montomoli, Claudia Sardu, Alessandro Sanna, (unknown), Lorena Lorefice, Maria Giovanna Marrosu, Paolo Valera, Eleonora Cocco	22
11	Télédermatologie en milieu carcéral : étude rétrospective de 500 télé-expertises 2016 ·Annales de Dermatologie et de Vénéréologie ·(unknown), (unknown), (unknown), Matthieu Resche‐Rigon, Alessandro Sanna, (unknown), Martine Bagot, F. Guibal	14
12	Multiple Sclerosis and environmental factors. 2016 ·UNICA IRIS Institutional Research Information System (University of Cagliari) ·Joanna Izabela Lachowicz, Paolo Valera, Alessandro Sanna, Valeria Marina Nurchi, Guido Crisponi, Lorena Lorefice, Eleonora Cocco	1
13	Zinc and Other Metals Deficiencies and Risk of Type 1 Diabetes: An Ecological Study in the High Risk Sardinia Island 2015 ·PLoS ONE ·Paolo Valera, Patrizia Zavattari, Alessandro Sanna, (unknown), (unknown), (unknown), Clara Targhetta, Graziella Bruno, Marco Songini	36
14	Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine 2013 ·Leukemia ·Ana Valencia, Erico Masala, (unknown), Alessandro Di Martino, Alessandro Sanna, Francesca Buchi, Federico Canzian, Daniela Cilloni, Valentina Gaidano, Maria Teresa Voso, Olivier Kosmider, Michaëla Fontenay, Antonella Gozzini, Alberto Bosi, Valeria Santini	70
15	Decitabine In Advanced Chronic Myelomonocytic Leukemia 2013 ·Blood ·Valeria Santini, Bernardino Allione, Alessandro Levis, Daniela Gioia, Monia Lunghi, Antonella Poloni, Daniela Cilloni, Gina Zini, Alessandro Sanna, (unknown), Adelmo Terenzi, Emanuele Angelucci, Carlo Finelli, Francesco Onida, Giuseppe Rossi, Dario Ferrero, Giuseppe Saglio, (unknown)	1
16	Distinct Signal Transduction Abnormalities and Erythropoietin Response in Bone Marrow Hematopoietic Cell Subpopulations of Myelodysplastic Syndrome Patients 2012 ·Clinical Cancer Research ·Elena Spinelli, Roberto Caporale, Francesca Buchi, Erico Masala, Antonella Gozzini, Alessandro Sanna, (unknown), Ana Valencia, Alberto Bosi, Valeria Santini	25
17	A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria 2012 ·Cytometry Part B Clinical Cytometry ·Francesco Mannelli, Sara Bencini, Benedetta Peruzzi, (unknown), Alessandro Sanna, Matteo Benelli, Alberto Magi, Giacomo Gianfaldoni, Giada Rotunno, Valentina Carrai, (unknown), (unknown), Valeria Santini, Rosario Notaro, Lucio Luzzatto, Alberto Bosi	5
18	Proteomic analysis identifies differentially expressed proteins in AML1/ETO acute myeloid leukemia cells treated with DNMT inhibitors azacitidine and decitabine 2012 ·Leukemia Research ·Francesca Buchi, Elena Spinelli, Erico Masala, Antonella Gozzini, Alessandro Sanna, Alberto Bosi, Germano Ferrari, Valeria Santini	17
19	Hepcidin Levels and Their Determinants in Different Types of Myelodysplastic Syndromes 2011 ·PLoS ONE ·Valeria Santini, Domenico Girelli, Alessandro Sanna, Nicola Martinelli, Lorena Duca, Natascia Campostrini, Agostino Cortelezzi, Michela Corbella, Alberto Bosi, Gianluigi Reda, Oliviero Olivieri, Maria Domenica Cappellini	107
20	317 Influence of mild bone marrow fibrosis on response of int-2/high risk MDS patients to 5-azacitidine 2011 ·Leukemia Research ·Alessandro Sanna, Antonella Gozzini, Irene Donnini, Cristina Clissa, Valentina Carrai, (unknown), Giada Rotunno, Alberto Bosi, Carlo Finelli, Giorgina Specchia, Valeria Santini	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact